Paediatric MS is the same disease as adult MS: No

Multiple Sclerosis Journal

Volumn 19, Issue 10, 2013, Pages 1255-1256

  Chitnis, Tanuja ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; OLIGOCLONAL BAND;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; CHILDHOOD DISEASE; CHRONIC INFLAMMATION; COGNITIVE DEFECT; EPSTEIN BARR VIRUS; EXPANDED DISABILITY STATUS SCALE; FOLLOW UP; HUMAN; MULTIPLE SCLEROSIS; MYELINATION; NEUTROPHIL COUNT; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; RECURRENCE RISK; RISK ASSESSMENT; TH17 CELL; TREATMENT RESPONSE; VITAMIN DEFICIENCY;

ADULT; AGE OF ONSET; CHILD; HUMANS; MULTIPLE SCLEROSIS;

EID: 84883395372     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513488842     Document Type: Note

References (11)

1. Gorman MP, Healy BC, Polgar-Turcsanyi M, et al. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol. 2009 ; 66: 54-59
2. Yeh EA, Weinstock-Guttman B, Ramanathan M, et al. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis. Brain. 2009 ; 132: 3392-3400
3. Banwell B, Bar-Or A, Arnold DL, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A prospective national cohort study. Lancet Neurol. 2011 ; 10: 436-445
4. Amato MP, Goretti B, Ghezzi A, et al. Cognitive and psychosocial features in childhood and juvenile MS: Two-year follow-up. Neurology. 2010 ; 75: 1134-1140
5. Julian L, Serafin D, Charvet L, et al. Cognitive impairment occurs in children and adolescents with multiple sclerosis: Results from a United States network. J Child Neurol. 2013 ; 28: 102-107
6. Chabas D, Castillo-Trivino T, Mowry EM, et al. Vanishing MS T2-bright lesions before puberty: A distinct MRI phenotype?. Neurology. 2008 ; 71: 1090-1093
7. Sadaka Y, Verhey LH, Shroff MM, et al. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Ann Neurol. 2012 ; 72: 211-223
8. Chabas D, Ness J, Belman A, et al. Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology. 2010 ; 74: 399-405
9. Vargas-Lowy D, Kivisakk P, Gandhi R, et al. Increased Th17 response to myelin peptides in pediatric MS. Clin Immunol. 2012 ; 146: 176-184
10. Chitnis T, Tenembaum S, Banwell B, et al. Consensus statement: Evaluation of new and existing therapeutics for pediatric multiple sclerosis. Mult Scler. 2012 ; 18: 116-127
11. Chitnis T, Tardieu M, Amato MP, et al. International Pediatric MS Study Group Clinical Trials Summit: Meeting report. Neurology. 2013 ; 80: 1161-1168